Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sabrina Klank"'
Autor:
Christina van Stein, Sabrina Klank, Marianne Grüneberg, Chris Ottolenghi, Jürgen Grebe, Janine Reunert, Erik Harms, Thorsten Marquardt
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-9 (2021)
Abstract Background Nephropathic cystinosis is a rare and severe metabolic disease leading to an accumulation of cystine in lysosomes which especially harms kidney function. A lifelong therapy with the aminothiol cysteamine can delay the development
Externí odkaz:
https://doaj.org/article/ddffc458daa14fa99fefae8128571e38
Autor:
Sabrina Klank, Christina van Stein, Marianne Grüneberg, Chris Ottolenghi, Kerstin K. Rauwolf, Jürgen Grebe, Janine Reunert, Erik Harms, Thorsten Marquardt
Publikováno v:
Pharmaceutics, Vol 15, Iss 7, p 1851 (2023)
Cystinosis is a severe inherited metabolic storage disease caused by the lysosomal accumulation of cystine. Lifelong therapy with the drug cysteamine bitartrate is necessary. Cysteamine cleaves intralysosomal cystine, and thereafter, it can exit from
Externí odkaz:
https://doaj.org/article/859fc65246174d6086cf631b3dd3dd5a
Autor:
Simone Linden, Sabrina Klank, Erik Harms, Marianne Grüneberg, Julien H. Park, Thorsten Marquardt
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 24, Iss , Pp 100620- (2020)
Background: Cystinosis is a metabolic disease caused by intracellular accumulation of cystine within lysosomes. Development of symptoms can be delayed significantly by a life-long therapy with cysteamine, a drug that enters the lysosome and reacts wi
Externí odkaz:
https://doaj.org/article/5f6ab042ba6a426f83db04a143bb4dd6
Autor:
Marquardt, Sabrina Klank, Christina van Stein, Marianne Grüneberg, Chris Ottolenghi, Kerstin K. Rauwolf, Jürgen Grebe, Janine Reunert, Erik Harms, Thorsten
Publikováno v:
Pharmaceutics; Volume 15; Issue 7; Pages: 1851
Cystinosis is a severe inherited metabolic storage disease caused by the lysosomal accumulation of cystine. Lifelong therapy with the drug cysteamine bitartrate is necessary. Cysteamine cleaves intralysosomal cystine, and thereafter, it can exit from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::336cefc1ad8ac133b5485c200ec3d04c
Autor:
Sabrina Klank, Janine Reunert, Thorsten Marquardt, Jürgen Grebe, Erik Harms, Christina Esther van Stein, Chris Ottolenghi, Marianne Grüneberg
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-9 (2021)
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases
Background Nephropathic cystinosis is a rare and severe metabolic disease leading to an accumulation of cystine in lysosomes which especially harms kidney function. A lifelong therapy with the aminothiol cysteamine can delay the development of end-st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71c7d2b9312cd82e1e2882227bcda1c0
https://doaj.org/article/ddffc458daa14fa99fefae8128571e38
https://doaj.org/article/ddffc458daa14fa99fefae8128571e38
Autor:
Julien H. Park, Marianne Grüneberg, Erik Harms, Thorsten Marquardt, Sabrina Klank, Simone Linden
Publikováno v:
Molecular Genetics and Metabolism Reports
Molecular Genetics and Metabolism Reports, Vol 24, Iss, Pp 100620-(2020)
Molecular Genetics and Metabolism Reports, Vol 24, Iss, Pp 100620-(2020)
Background Cystinosis is a metabolic disease caused by intracellular accumulation of cystine within lysosomes. Development of symptoms can be delayed significantly by a life-long therapy with cysteamine, a drug that enters the lysosome and reacts wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a1fee8189b1d4b7e6158b661de4fb72
https://pubmed.ncbi.nlm.nih.gov/32685378
https://pubmed.ncbi.nlm.nih.gov/32685378